Skip to main content
SpringerLink
Log in

Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

Obesity is an established risk factor for endometrial cancer. Leptin, a secreted protein of the ob gene by white adipose tissue, plays an important role in the regulation of food intake and energy consumption in the brain and acts as a potential growth stimulator in normal and neoplastic cancer cells. However, a direct role for leptin in endometrial cancer has not been demonstrated. In the present study, the effect of leptin on the proliferation of Ishikawa endometrial cancer cells was investigated as well as the possible mechanism(s) underlying this action in endometrial cancers which express both short and long isoforms of leptin receptors. The expression of leptin receptor (ObRb) in Ishikawa cells was detected by RT-PCR and Western blotting. The cells after serum starvation, were treated by leptin with various concentrations (0, 10, 50, 100, 150 ng/mL) for different durations (6, 12, 24 h). The effect of leptin treatment on cell proliferation was examined by MTT assay. Meanwhile, inhibitory effect of Janus tyrosine kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) inhibitor AG490 or extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitor PD98059 on the proliferation of Ishikawa cells induced by leptin was also studied. Ishikawa cells were treated with 100 ng/mL leptin for various periods (0, 20, 40, 60 min), and the levels of STAT3 phosphorylation and ERK1/2 phosphorylation were examined by Western blotting. The results showed that leptin induced the phosphorylation of STAT3 and the activation of ERK1/2 in a time- and dose-dependent manner in the Ishikawa endometrial cancer cells. Blocking STAT3 phosphorylation with the inhibitor AG490, or blocking ERK1/2 activation by the specific ERK1/2 kinase inhibitor, PD98059, abolished leptin-induced proliferation of Ishikawa cells. In addition, leptin was found to potently induce the invasion of endometrial cancer cells in a Matrigel invasion assay. Leptin-stimulated invasion was effectively blocked by pharmacological inhibitors of STAT3 (AG490) and ERK1/2 kinase (PD98059). These results suggested that leptin promotes endometrial cancer growth and invasiveness by activating STAT3 and ERK1/2 signaling pathways and therefore blocking its action at the receptor level can be a rational therapeutic strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature,1994,372(6):425–432

    Article  PubMed  CAS  Google Scholar 

  2. Caro JF, Sinha MK, Kolaczynski JW, et al. Leptin: the tale of an obesity gene. Diabetes, 1996,45(12):1455–1462

    PubMed  CAS  Google Scholar 

  3. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature, 1998,395(5):763–770

    Article  PubMed  CAS  Google Scholar 

  4. Lonnqvist F, Arner P, Nordfors L, et al. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med, 1995,1(8):950–955

    Article  PubMed  CAS  Google Scholar 

  5. Bouloumie A, Drexler HC, Lafontan M, et al. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res, 1998,83(10):1059–1066

    PubMed  CAS  Google Scholar 

  6. Sierra-Honigmann MR, Nath AK, Murakami C, et al. Biological action of leptin as an angiogenicfactor. Science, 1998,281(12):1683–1686

    Article  PubMed  CAS  Google Scholar 

  7. Huang L, Li C. Leptin: a multifunctional hormone. Cell Res, 2000,10(1):81–92

    Article  PubMed  CAS  Google Scholar 

  8. Somasundar P, Frankenberry KA, Skinner H, et al. Prostate cancercell proliferation is influenced by leptin. J Sur Res, 2004,118(1):71–82

    Article  CAS  Google Scholar 

  9. Somasunder P, McFadden DW, Hileman SM, et al. Leptin is a growth factor in cancer. J Sur Res, 2004, 116(4):337–349

    Article  Google Scholar 

  10. White DW, Tartaglia LA. Leptin and OB-R: body weight regulation by a cytokine receptor. Cytokine Growth Factor Rev, 1996,7(3):303–309

    Article  PubMed  CAS  Google Scholar 

  11. Fei H, Okano HJ, Li C, et al. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci USA, 1997,94(11):7001–7005

    Article  PubMed  CAS  Google Scholar 

  12. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell, 1995,83(10):1263–1271

    Article  PubMed  CAS  Google Scholar 

  13. Banks AS, Davis SM, Bates SH, et al. Activation of downstream signals by the long form of the leptin receptor. J Biol Chem, 2000,275(7):14563–14572

    Article  PubMed  CAS  Google Scholar 

  14. Rose PG. Endometrial carcinoma. N Engl J Med, 1996, 335(6):640–649

    Article  PubMed  CAS  Google Scholar 

  15. Judd HL, Shamonki IM, Frumar AM, et al. Origin of serum estradiol in postmenopausal women. Obstet Gynecol, 1982,59(8):680–686

    PubMed  CAS  Google Scholar 

  16. Deslypere JP. Obesity and cancer. Metabolism, 1995, 44(1):24–27

    Article  PubMed  CAS  Google Scholar 

  17. Carroll KK. Obesity as a risk factor for certain types of cancer. Lipids, 1998,33(9):1055–1059

    Article  PubMed  CAS  Google Scholar 

  18. Petridou E, Belechri M, Dessypris N, et al. Leptin and body mass index in relation to endometrialcancer risk. Ann Nutr & Metab, 2002,46(2):147–151

    Article  CAS  Google Scholar 

  19. Yuan SS, Tsai KB, Chung YF, et al. Aberrant expression and possibleinvolvement of the leptin receptor in endometrial cancer. Gynecol Oncol, 2004,92(7):769–775

    Article  PubMed  CAS  Google Scholar 

  20. Koda M, Sulkowska M, Wincewicz A, et al. Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer. Ann N Y Acad Sci, 2007,95(1):90–98

    Article  Google Scholar 

  21. Cymbaluk A, Chudecka-Glaz A, Rzepka-Gorska I. Leptin levels in serum depending on body mass index in patients with endometrial hyperplasia and cancer. Eur J Obstet Gynecol Reprod Biol, 2006,26(9):629–640

    Google Scholar 

  22. Ahima RS, Osei SY. Leptin signaling. Physi Behav 2004, 81(3):223–241

    Article  CAS  Google Scholar 

  23. Bjorbeak C, Buchholz RM, Davis SM, et al. Divergent roles of SHP-2 in ERK activation by leptin receptors. J Biol Chem, 2001,276(5):4747–4755

    Article  Google Scholar 

  24. Dien J, Amin HM, Chiu N, et al. Signal transducers and activators of transcription-3 up-regulates tissue inhibitor of metalloproteinase-1 expression and decreases invasiveness of breast cancer. Am J Pathol, 2006,169(5): 633–642

    Article  PubMed  CAS  Google Scholar 

  25. Suiqing C, Min Z, Lirong C. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell arcinoma. J Dermatol, 2005,32(4):354–360

    PubMed  Google Scholar 

  26. Choo MK, Sakurai H, Koizumi K, et al. Stimulation of cultured colon 26 cells with TNF-alpha promotes lung metastasis through the extracellular signal-regulated kinase pathway. Cancer Lett, 2005,230(1):47–55

    Article  PubMed  CAS  Google Scholar 

  27. Lama G, Mangiola A, Anile C, et al. Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue. Int J Oncol, 2007,30(11):1333–1342

    PubMed  CAS  Google Scholar 

  28. Pai R, Lin C, Tran T, et al. Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation. Biochem Biophys Res Commun, 2005,331(8): 984–992

    Article  PubMed  CAS  Google Scholar 

  29. Hu X, Juneja SC, Maihle NJ, et al. Leptin-A growth factor in normal and malignant breast cells and for normal mammary gland development. J Nati Cancer Inst, 2002,94(10):1704–1711

    CAS  Google Scholar 

  30. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev, 2004,5(2):153–165

    Article  PubMed  CAS  Google Scholar 

  31. Choi JH, Park SH, Leung PC, et al. Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. J Clinl Endocrin Metab, 2005,90(2): 207–210

    CAS  Google Scholar 

  32. Baumann H, Morella KK, White DW, et al. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci USA, 1996,93(9):8374–8388

    Article  PubMed  CAS  Google Scholar 

  33. Tanabe K, Okuya S, Tanizawa Y, et al. Leptin induces proliferation of pancreatic beta cell line MIN6 through activation of mitogen-activated protein kinase. Biochem Biophys Res Commun, 1997,241(6):765–768

    Article  PubMed  CAS  Google Scholar 

  34. Bendinelli P, Maroni P, Pecori Giraldi F, et al. Leptin activates Stat3, Stat1 and AP-1 in mouse adipose tissue. Mol Cell Endocrinol, 2000,168(1):11–20

    Article  PubMed  CAS  Google Scholar 

  35. Zabeau L, Lavens D, Peelman F, et al. The ins and outs of leptin receptor activation. FEBS Lett, 2003,546(1):45–55

    Article  PubMed  CAS  Google Scholar 

  36. Bowman T, Garcia R, Turkson J, et al. STATs in oncogenesis. Oncogene, 2000,19(7):2474–2488

    Article  PubMed  CAS  Google Scholar 

  37. Barre B, Avril S, Coqueret O. Opposite regulation of myc and p21waf1 transcription by STAT3 proteins. J Biol Chem, 2003,278(4):2990–2996

    Article  PubMed  CAS  Google Scholar 

  38. Kiuchi N, Nakajima K, Ichiba M, et al. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med, 1999,189(1):63–73

    Article  PubMed  CAS  Google Scholar 

  39. Shirogane T, Fukada T, Muller JM, et al. Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity, 1999,11(6):709–719

    Article  PubMed  CAS  Google Scholar 

  40. Catlett-Falcone R, Landowski TH, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity, 1999, 10(2):105–115

    Article  PubMed  CAS  Google Scholar 

  41. Giraud S, Bienvenu F, Avril S, et al. Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. J Biol Chem, 2002,277(8):8004–8011

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Yi Liu  (刘 义), Liqun Lv  (吕立群), Wei Xiao  (肖 维), Cheng Gong  (龚 成), Jie Yin  (尹 婕), Donghua Wang  (王冬花) & Hui Sheng  (盛 慧)

Authors
  1. Yi Liu  (刘 义)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liqun Lv  (吕立群)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei Xiao  (肖 维)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cheng Gong  (龚 成)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jie Yin  (尹 婕)
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Donghua Wang  (王冬花)
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hui Sheng  (盛 慧)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yi Liu  (刘 义).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Y., Lv, L., Xiao, W. et al. Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 31, 365–370 (2011). https://doi.org/10.1007/s11596-011-0382-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-011-0382-7

Key words

Search

Navigation